We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+5.18%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+549.41%
AUM
$199B
AUM Growth
+$14.7B
Cap. Flow
+$6.96B
Cap. Flow %
3.51%
Top 10 Hldgs %
15.28%
Holding
4,151
New
137
Increased
3,049
Reduced
464
Closed
123

Sector Composition

Rank Sector Weight
1 Technology 15.06%
2 Financials 14.21%
3 Healthcare 14.12%
4 Industrials 10.19%
5 Consumer Discretionary 9.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JRJC
3176
DELISTED
China Finance Online Co., Ltd.
JRJC
$509K ﹤0.01%
11,824
+4,707
+66% +$206K
RGT
3177
Royce Global Value Trust
RGT
$102M
$507K ﹤0.01%
+62,446
New +$496K
RELX icon
3178
RELX
RELX
$62.2B
$506K ﹤0.01%
26,425
-1,608
-6% -$30.7K
CPRX
3179
DELISTED
Catalyst Pharmaceutical
CPRX
$501K ﹤0.01%
460,267
+241
+0.1% +$217
DRNA
3180
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$501K ﹤0.01%
85,210
+74
+0.1% +$259
RDS.A
3181
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$500K ﹤0.01%
10,343
-294
-3% -$14.4K
SCYX icon
3182
SCYNEXIS
SCYX
$54.8M
$498K ﹤0.01%
1,609
+919
+133% +$194K
INFI
3183
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$498K ﹤0.01%
319,410
+4,009
+1% +$6.16K
AEGR
3184
DELISTED
Aegerion Pharmaceuticals
AEGR
$496K ﹤0.01%
167,216
+77
+0% +$133
EML icon
3185
Eastern Company
EML
$151M
$495K ﹤0.01%
24,738
+23
+0.1% +$426
UBS icon
3186
UBS Group
UBS
$176B
$494K ﹤0.01%
36,272
BWFG icon
3187
Bankwell Financial Group
BWFG
$530M
$491K ﹤0.01%
20,768
+762
+4% +$17.2K
AQMS icon
3188
Aqua Metals
AQMS
$9.88M
$490K ﹤0.01%
277
+6
+2% +$11.3K
ALR
3189
DELISTED
AlerisLife Inc
ALR
$489K ﹤0.01%
25,632
+4,371
+21% +$93.4K
NEOS
3190
DELISTED
Neos Therapeutics, Inc
NEOS
$489K ﹤0.01%
74,381
+25,871
+53% +$205K
LPCN icon
3191
Lipocine
LPCN
$18M
$488K ﹤0.01%
6,445
+261
+4% +$16.2K
MOMO
3192
Hello Group
MOMO
$864M
$488K ﹤0.01%
21,730
+3,425
+19% +$60.7K
UEC icon
3193
Uranium Energy
UEC
$5.59B
$488K ﹤0.01%
494,453
COVS
3194
DELISTED
Covisint Corporation
COVS
$484K ﹤0.01%
222,208
+169
+0.1% +$369
OXFD
3195
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$483K ﹤0.01%
38,507
+2,271
+6% +$22.8K
SYRS
3196
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$481K ﹤0.01%
+3,475
New +$441K
JCAP
3197
DELISTED
Jernigan Capital, Inc.
JCAP
$480K ﹤0.01%
25,051
MHGC
3198
DELISTED
Morgans Hotel Group Co.
MHGC
$478K ﹤0.01%
237,302
+19,367
+9% +$43.1K
GIC icon
3199
Global Industrial
GIC
$1.49B
$477K ﹤0.01%
60,290
+1,011
+2% +$8.51K
ING icon
3200
ING
ING
$102B
$477K ﹤0.01%
38,721
+10,246
+36% +$119K

Similar funds

Geode Capital Management's Q3 2016 Portfolio in Review

As of Q3 2016, Geode Capital Management held 4,151 positions worth $199B, up 8% from $184B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Geode Capital Management deployed $6.96B of net new capital in Q3 2016, opening 137 new positions and adding to 3,049 existing holdings. Its largest new stake was Fortive: 4,005,895 shares worth $128M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Danaher, an estimated $103M trimmed.

  • Geode Capital Management's largest Q3 2016 buy was Fortive: 4,005,895 shares worth $128M.
  • Geode Capital Management added most to Johnson & Johnson in Q3 2016, an estimated $150M increase.
  • Geode Capital Management's biggest Q3 2016 reduction was Danaher, cutting an estimated $103M.
  • Geode Capital Management fully exited EMC CORPORATION in Q3 2016, selling an estimated $437M.
  • Geode Capital Management's ten largest holdings make up 15% of its $199B portfolio in Q3 2016.
  • Geode Capital Management opened 137 new positions and closed 123 in Q3 2016.
  • Geode Capital Management's portfolio value rose 8% quarter-over-quarter to $199B.

Based on Geode Capital Management's 13F filing for Q3 2016, filed 10 Nov 2016.